Using a transmission dynamic model to estimate annual HIV incidence rate among drug users in China
-
摘要: 目的 通过构建传染病动力学模型,估计1995-2014年我国吸毒人群中人类免疫缺陷病毒(human immunodeficiency virus,HIV)的年发病率。方法 构建HIV在我国吸毒人群中的传播动力学模型,通过查阅文献收集模型运行所需输入参数。基于国家监测的吸毒者HIV患病率数据进行模型的训练与测试后,利用蒙特卡罗模拟实现贝叶斯合并方法(bayesian melding approach)对发病率的估计。结果 包含易感者、HIV感染者和艾滋病患者三个状态的模型经训练后对HIV患病率的平均相对预测误差为4.37%,模型输出患病率与实际患病率拟合优度较高(R2=0.89,P<0.001)。模型估计的HIV年发病率在1996年达到峰值(4.06%),其后逐渐下降,2000年低至1.25%,2002年发病率回升至1.95%,随后发病率逐年降低,2008年之后,发病率稳定在0.50%~0.90%之间。结论 应用传染病动力学模型较好地模拟了我国吸毒人群HIV患病率,进而对发病率做出了准确估计。从降低发病率来看,我国采取的HIV综合防控措施对控制HIV在吸毒人群中的传播取得了一定效果。Abstract: Objective To estimate annual human immunodeficiency virus (HIV) incidence rate among drug users in China from 1995 to 2014 based on a transmission dynamic model. Methods An HIV transmission dynamic model was developed to describe the HIV epidemic among drug users in China. The model was parameterized using data from literature available. The incidence rate was estimated through Bayesian melding approach achieved by Monte Carlo simulation after training and testing the model based on HIV prevalence data from national sentinel sites. Results The trained model consisting of three compartments (susceptible, HIV infected and AIDS patients) predicted HIV prevalence precisely with small average relative error(4.37%).The model-predicted HIV prevalence fitted well to HIV prevalence data (R2=0.89, P<0.001). HIV incidence rate predicted by the model peaked in 1996(4.06%), then decreased to 1.25% in 2000. It rose again to 1.95% in 2002 and continued to decrease until around 2008 to 2014 when it leveled off between 0.50% and 0.90%. Conclusions The model was able to attain a good fit to HIV prevalence data, allowing for reasonably precise estimate of the incidence rate, which showed that HIV comprehensive prevention and control measures in China had positive impact on reducing HIV incidence rate among drug users.
-
Key words:
- Human immunodeficiency virus /
- Incidence rate /
- Epidemiologic studies
-
国家禁毒委员会. 2015年中国禁毒报告 [R]. 北京, 2015. 梁均和,陈安妮,蔡惠霞,等. 江门市吸毒人群高危行为及HIV、梅毒、HBV、HCV感染状况调查 [J]. 华南预防医学, 2005,31(3):15-16. 中华人民共和国卫生部,联合国艾滋病规划署,世界卫生组织. 2009年中国艾滋病疫情估计工作报告 [R]. 北京, 2010. 晓编. 我国艾滋病疫情最新发布 [N]. 中国医学论坛报, 2014-12-04(A-11). Dou Z, Chen RY, Wang Z, et al. HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985-2008 [J]. PLoS One, 2010,5(10):e13737. Kermack WO, McKendrick AG. A contribution to the mathematical theory of epidemics [J]. Proc Roy Soc, 1927,115(772):700-721. Zhang F, Dou Z, Ma Y, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study [J]. Lancet Infect Dis, 2011,11(7):516-524. 国家禁毒委员会. 2005年中国禁毒报告[R]. 北京, 2005. 刘慧鑫,王璐,秦倩倩,等. 滞后诊断偏倚对判断艾滋病潜伏期的影响 [J]. 中华流行病学杂志, 2011,32(9):892-895. 童光来,窦媛媛. 戒毒成功率为何低至2% [N]. 北京科技报, 2005-06-22(40). Mathers BM, Degenhardt L, Bucello C, et al. Mortality among people who inject drugs: a systematic review and meta-analysis [J]. Bull World Health Organ, 2013,91(2):102-123. 朱玉,尹潞,阮玉华,等. 四川省西昌市静脉吸毒人群3年随访的死亡情况分析 [J]. 中国自然医学杂志, 2006,8(3):170-174. 王霞,丁心平,苏斌,等. 安徽省既往献血员HIV感染后生存时间和抗病毒治疗效果研究 [J]. 中华流行病学杂志, 2009,30(11):1135-1138. Liu E, Rou K, McGoogan JM, et al. Factors associated with mortality of HIV-positive clients receiving methadone maintenance treatment in China [J]. J Infect Dis, 2013,208(3):442-453. 徐翠玲,王爱民,陈芳,等. 织金县吸毒人群HIV发病率回顾性队列研究 [J]. 中国艾滋病性病, 2005,11(1):13-15. 韩梅,王豫林,王憨杰,等. 应用BED-CEIA方法估算重庆市静脉吸毒人群艾滋病病毒感染的发病率 [J]. 中华流行病学杂志, 2007,28(11):1077-1080. 刘莉,冯燎,罗映娟,等. 四川省1995-2012年吸毒者艾滋病流行趋势分析 [J]. 中华疾病控制杂志, 2014,18(8):702-705. 国家禁毒委员会. 1998年中国禁毒报告 [R]. 北京, 1998. Kwon JA, Anderson J, Kerr CC, et al. Estimating the cost-effectiveness of needle-syringe programs in Australia [J]. AIDS, 2012,26(17):2201-2210. Poole D, Raftery A. Inference for deterministic simulation models: the bayesian melding approach [J]. Am Stat Assoc, 2000,95(452):1244-1255. 中华人民共和国国家卫生和计划生育委员会. 2014年中国艾滋病防治进展报告 [R]. 北京, 2014. Garnett GP, Cousens S, Hallett TB, et al. Mathematical models in the evaluation of health programmes [J]. Lancet, 2011,378(9790):515-525. Zhang L, Chow EP, Jing J, et al. HIV prevalence in China: integration of surveillance data and a systematic review [J]. Lancet Infect Dis, 2013,13(11):955-963. Barnighausen T, Tanser F, Hallett T, et al. Short communication: prioritizing communities for HIV prevention in sub-Saharan Africa [J]. AIDS Res Hum Retroviruses, 2010,26(4):401-405. 颜江瑛,陈秋兰,马彦民,等. 中国艾滋病综合防治政策发展及影响因素分析 [J]. 中华流行病学杂志, 2005,26(11):855-860.
点击查看大图
计量
- 文章访问数: 460
- HTML全文浏览量: 97
- PDF下载量: 86
- 被引次数: 0